Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
acidophilus LA-14, and Saccharomyces cerevisiae ssp
Weight loss injections like semaglutide (Wegovy) and tirzepatide (Zepbound) have become important FDA-approved treatments for chronic weight management in the United States
In the new substudy, once weekly semaglutide (1 mg) was shown to reduce the risk of time to first composite HF event (new onset or worsening HF leading to unscheduled hospital admission or urgent visit, with initiation of or intensified diuretic/vasoactive therapy) or cardiovascular death and HF events and cardiovascular death alone
Metabolomic profiling was restricted to plasma, and the combined nature of the dietary intervention precludes attribution of effects to individual dietary components
This hormone is normally released by the intestines in response to food and plays a key role in regulating blood sugar by stimulating insulin production and suppressing the release of glucagon, another hormone that raises blood sugar levels
